LRRK2 and Parkinson disease: However, the differential vulnerability of midbrain dopaminergic neurons in PD, combined with what we now know about the cell-type-specific effects of LRRK2 mutation in other regions and cell types, compels a finer dissection of the differential effects of LRRK2 among neuron subtypes in the dopaminergic midbrain.